Gilbert and Crigler -Najjar syndromes are familial unconjugated hyperbilirubinemias caused by genetic lesions involving a single complex locus encoding for bilirubin UDP-glucuronosyltransferase (UGT1A1) gene. Over the last years, a number of different mutations affecting this gene have been characterized. In this report is provided a summary of reported Gilbert and Crigler -Najjar syndromes-associated UGT1A1 gene mutations. D
Water-insoluble bilirubin, which results from breakdown products of heme, is a toxic compound. Hepatic glucuronization of this insoluble bilirubin is catalyzed by isoenzyme 1A1 of UDP-glucuronosyltransferase (UGT1A1), which is essential for efficient biliary excretion of bilirubin [1, 2] . Mutations in the UGT1A1 gene (UGT1A1; MIM#191740) are responsible for both Gilbert and Crigler -Najjar syndromes. Genetic alterations causing absence, or severe reduction, of UGT1A1 enzymatic activity, result respectively in Crigler -Najjar syndrome type I and type II [1 -5] . The clinical classification of Crigler-Najjar syndrome types I and II is based on the bilirubin levels, the presence of kernictus and the reduction of the bilirubin levels upon administration of phenobarbital or other enzyme-inducing agents [3, 4] . Type I Crigler -Najjar syndrome is characterized by almost complete absence of UGT1A1 enzyme activity, with serum bilirubin levels of 340 -685 Amol/l or higher and is refractory to phenobarbital treatment. In type II Crigler -Najjar syndrome, enzyme activity is severely reduced, with a serum bilirubin level of 100 -340 Amol/l. Enzyme activity can be induced by phenobarbital treatment [3, 4] . Mild hyperbilirubinemia, usually less than 50 Amol/l, is associated with Gilbert Syndrome and thought to reflect a small reduction in UGT1A1 activity (approximately 30%) [2] . UGT1A1 protein is encoded by five consecutive exons located at the 3V end of the UGT1A locus [5] .
Gilbert and Crigler -Najjar Syndromes gene mutations are shown in Table 1 . The nucleotide numbers shown in this table are based on the cDNA sequence in the GenBank, accession number NM _ 000463.2. The recommended numbering convention used in this tabulation assigns ''1'' to the A of the initiator ATG codon. Mutations are described according to the recommendations of the Human Genome Variation Society (www.hgvs.org). b) Homozygosity for this mutation was described in association with CN2. c) This mutation was described in trans with other mutation. d) Homozygosity for this mutation was described in association with CN1. GS: Gilbert syndrome. CN1: Crigler -Najjar Syndrome type I. CN2: Crigler -Najjar Syndrome type II. a The phenotype associated is related with the first description of the mutation. 
